Extended Stability of Reconstituted Lyophilized Erwinia L-asparaginase in Vials
Conclusion: It is feasible to reuse the remaining content of ERW-ASNase vial after reconstitution, which allows the optimization of the content of ERW-ASNase vials use and reduces the cost of this formulation usage, making it more accessible.
Source: In Vivo - Category: Research Authors: VINA-ROMERO, M. M., RAMOS-DIAZ, R., MOURANI-PADRON, I., GONZALEZ-MENDEZ, H., GONZALEZ-CRUZ, M., NAZCO-CASARIEGO, G. J., MERINO-ALONSO, J. F., DIAZ-VERA, J., GUTIERREZ-NICOLAS, F. Tags: Experimental Studies Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Leukemia | Men | Pediatrics | Research | Study